A
ADC Therapeutics SA
ADCT
3.06000
USD
-0.26
(-7.83%)
مغلق
حجم التداول
5,003
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
272,659,339
الأخبار
العنوان: ADC Therapeutics SA
القطاع: Healthcare
الصناعة: Biotechnology
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.